Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes

Heart Failure Clinics
Anil K Agarwal, Ajay K Singh

Abstract

The effect of erythropoiesis-stimulating agents (ESAs) on renal and cardiovascular outcomes in patients with chronic kidney disease (CKD) and heart failure (HF) is uncertain. Observational data indicate a strong relationship between the severity of anemia and poor outcome. On the other hand, randomized controlled trials on patients with CKD indicate that ESAs used in targeting a higher hemoglobin concentration result in increased risk. This article reviews the observational data as well as the recent information from randomized trials that point to increased risk in CKD and HF settings, and whether these disparate results can be explained by exposure to ESAs in this setting.

References

Mar 1, 1975·Circulation Research·B D MyersB M Brenner
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D L GarciaB M Brenner
Nov 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D RothC A Shadur
May 20, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C van Ypersele de Strihou
Feb 7, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P JungersN K Man
Oct 9, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·N Muirhead
Oct 25, 2001·Journal of the American Society of Nephrology : JASN·Allan J CollinsWillard Manning
Jan 10, 2002·Journal of Cardiac Failure·C A PolanczykT G Di Salvo
Feb 15, 2003·The American Journal of Medicine·Mikhail KosiborodHarlan M Krumholz
Mar 13, 2003·Kidney International·William F KeaneUNKNOWN RENAAL Study Investigators
Apr 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kunitoshi IsekiShuichi Takishita
Apr 30, 2003·Diabetes Care·Hideki UedaYoshiki Nishizawa
Aug 29, 2003·The American Journal of Cardiology·G Michael FelkerChristopher M O'Connor
Aug 26, 2004·Kidney International·Michael CusickUNKNOWN Early Treatment Diabetic Retinopathy Study Research Group
Oct 20, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Yi ZhangDennis J Cotter
May 20, 2005·Journal of the American Society of Nephrology : JASN·Patrick S ParfreyDieter Frei
Mar 28, 2006·Journal of the American Society of Nephrology : JASN·Deborah L RegidorKamyar Kalantar-Zadeh
Nov 17, 2006·The New England Journal of Medicine·Tilman B DrüekeUNKNOWN CREATE Investigators
Nov 17, 2006·The New England Journal of Medicine·Ajay K SinghUNKNOWN CHOIR Investigators
Dec 25, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Brian D BradburyJohn F Acquavella
Jan 16, 2008·Circulation·Jalal K GhaliUNKNOWN Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group
Feb 2, 2008·Journal of the American College of Cardiology·W H Wilson TangJames B Young
Sep 2, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Elani StrejaKamyar Kalantar-Zadeh
Mar 6, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Yi ZhangMiguel A Hernán
Jul 7, 2009·Journal of the American Society of Nephrology : JASN·Ajay K Singh
Jul 25, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Karen S ServillaPhilip G Zager
Nov 3, 2009·The New England Journal of Medicine·Marc A PfefferUNKNOWN TREAT Investigators
Dec 19, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Ouhong WangJohn F Acquavella

❮ Previous
Next ❯

Citations

Feb 14, 2013·Clinical Interventions in Aging·Ravish Shah, Anil K Agarwal
Dec 15, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Thomas ParkerRichard J Glassock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Ioannis KoulouridisBertrand L Jaber
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Y M K FaragAjay K Singh
© 2021 Meta ULC. All rights reserved